Thursday June 3, 1999 - Question 10

Which of the following statements regarding rofecoxib (Vioxx®) is correct?

A. Rofecoxib is only FDA approved to treat post-operative dental pain.

B. Rofecoxib is the second approved drug commonly referred to as a “Cox-2 inhibitor”.

C. Product labeling for rofecoxib does not include a warning statement about ulcers and GI bleeding.

D. Rofecoxib is expected to affect platelet aggregation.

E. Rofecoxib may be taken with ibuprofen or other NSAID products.
 
 

Discussion